Fortress Biotech shares rose after the pharmaceutical company said the Food and Drug Administration accepted a resubmitted New Drug Application for its Menkes disease treatment. The stock was up 10% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback